- Home
- MNSB vs EPRX Comparison
MNSB vs EPRX Comparison
Compare MNSB & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- EPRX
- Stock Information
- Founded
- MNSB 2003
- EPRX 2011
- Country
- MNSB United States
- EPRX Canada
- Employees
- MNSB N/A
- EPRX N/A
- Industry
- MNSB Major Banks
- EPRX
- Sector
- MNSB Finance
- EPRX
- Exchange
- MNSB Nasdaq
- EPRX NYSE
- Market Cap
- MNSB 140.7M
- EPRX 137.7M
- IPO Year
- MNSB N/A
- EPRX N/A
- Fundamental
- Price
- MNSB $18.30
- EPRX $4.32
- Analyst Decision
- MNSB
- EPRX Strong Buy
- Analyst Count
- MNSB 0
- EPRX 1
- Target Price
- MNSB N/A
- EPRX $9.00
- AVG Volume (30 Days)
- MNSB 23.4K
- EPRX 14.5K
- Earning Date
- MNSB 07-28-2025
- EPRX 08-07-2025
- Dividend Yield
- MNSB 2.17%
- EPRX N/A
- EPS Growth
- MNSB N/A
- EPRX N/A
- EPS
- MNSB N/A
- EPRX N/A
- Revenue
- MNSB $59,896,000.00
- EPRX N/A
- Revenue This Year
- MNSB $17.95
- EPRX N/A
- Revenue Next Year
- MNSB $2.52
- EPRX N/A
- P/E Ratio
- MNSB N/A
- EPRX N/A
- Revenue Growth
- MNSB N/A
- EPRX N/A
- 52 Week Low
- MNSB $15.00
- EPRX $2.20
- 52 Week High
- MNSB $20.88
- EPRX $4.49
- Technical
- Relative Strength Index (RSI)
- MNSB 45.27
- EPRX N/A
- Support Level
- MNSB $18.00
- EPRX N/A
- Resistance Level
- MNSB $18.52
- EPRX N/A
- Average True Range (ATR)
- MNSB 0.46
- EPRX 0.00
- MACD
- MNSB -0.07
- EPRX 0.00
- Stochastic Oscillator
- MNSB 24.65
- EPRX 0.00
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.